{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:38:23Z","timestamp":1792787903727,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T00:00:00Z","timestamp":1786233600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":51,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Natural Science Foundation of China","award":["81871088"],"award-info":[{"award-number":["81871088"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Hubei Province Health Science and Technology Project","award":["WJ2025M008"],"award-info":[{"award-number":["WJ2025M008"]}]},{"name":"Wuhan Natural Science Foundation Clinical Research Key Project of Municipal Medical Institutions","award":["2026020301040140"],"award-info":[{"award-number":["2026020301040140"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The C-reactive protein\u2013triglyceride glucose index (CTI) is a novel composite biomarker that integrates inflammation and insulin resistance. However, its association with the severity of coronary artery disease (CAD) in patients with H-type hypertension under different glucose metabolism statuses remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective study enrolled 1392 hypertensive patients who underwent coronary angiography. CTI was calculated as 0.412\u2009\u00d7\u2009ln(CRP[mg\/L])\u2009+\u2009ln(TG[mg\/dL]\u2009\u00d7\u2009FPG [mg\/dL]\/2). Patients were divided into three groups according to CTI tertiles: T1 group (6.748\u2009\u2264\u2009CTI\u2009&lt;\u20098.674), T2 group (8.674\u2009\u2264\u2009CTI\u2009&lt;\u20099.549), and T3 group (9.549\u2009\u2264\u2009CTI\u2009\u2264\u200912.713). Based on the Gensini score derived from coronary angiography, the study cohort was divided into three groups according to the severity of stenosis: low stenosis, medium stenosis, and high stenosis. Logistic regression, restricted cubic spline (RCS) analysis, and receiver operating characteristic (ROC) curve analysis were used to investigate the association between CTI and CAD severity across different glucose metabolism statuses and H\u2011type hypertension subgroups. Incremental utility of CTI was evaluated using receiver operating characteristic (ROC) curves, net reclassification improvement (NRI), integrated discrimination improvement (IDI), and decision curve analysis (DCA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The results show that CTI is significantly associated with CAD severity in hypertensive patients. After adjusting for risk factors, CTI remained significantly associated with multi-vessel CAD (OR\u2009=\u20092.155, 95%CI 1.839\u20132.455) and moderate-to-severe coronary stenosis (OR\u2009=\u20091.818, 95% CI 1.603\u20132.062). RCS analysis revealed a linear dose\u2013response relationship between CTI and CAD severity (P for non-linearity\u2009&gt;\u20090.05). Notably, we observed significant interaction between CTI and H-type hypertension on CAD severity (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.033). Under different glycemic statuses, high CTI levels were associated with CAD severity; however, no association between CTI and moderate\u2011to\u2011severe coronary stenosis was observed in patients with diabetes mellitus (DM). In the DM subgroup of patients with H-type hypertension, after adjustment for risk factors, patients in the T3 group had a\u00a06.475-fold increased risk\u00a0of multi-vessel CAD compared with those in the T1 group (95% CI 1.693\u201324.773,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.006). ROC analysis demonstrated that, across different glucose metabolism subgroups, CTI showed the highest discriminative ability for multi\u2011vessel CAD in patients with H\u2011type hypertension and comorbid DM (AUC\u2009=\u20090.712, 95% CI 0.619\u20130.804,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>CTI is an independently associated factor for coronary stenosis severity in patients with hypertension, particularly in those with H\u2011type hypertension and comorbid diabetes. This simple and cost\u2011effective composite biomarker holds promise as a practical tool for early risk stratification and for guiding individualized prevention strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12933-026-03318-6","type":"journal-article","created":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T12:53:32Z","timestamp":1786280012000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["C-reactive protein\u2013triglyceride glucose index for the detection of the severity of coronary artery disease in different glucose metabolic states in patients with H-type hypertension"],"prefix":"10.1186","volume":"25","author":[{"given":"Li","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Ming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9960-6173","authenticated-orcid":false,"given":"Xisheng","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,9]]},"reference":[{"issue":"25","key":"3318_CR1","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982\u20133021.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"3318_CR2","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1093\/eurjpc\/zwae022","volume":"31","author":"DF Wu","year":"2024","unstructured":"Wu DF, Yin RX, Deng JL. Homocysteine, hyperhomocysteinemia, and H-type hypertension. Eur J Prev Cardiol. 2024;31(9):1092\u2013103.","journal-title":"Eur J Prev Cardiol"},{"issue":"1","key":"3318_CR3","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/1753-0407.12333","volume":"8","author":"X Qin","year":"2016","unstructured":"Qin X, Huo Y. H-type hypertension, stroke and diabetes in China: opportunities for primary prevention. J Diabetes. 2016;8(1):38\u201340.","journal-title":"J Diabetes"},{"issue":"4","key":"3318_CR4","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1515\/jtim-2015-0027","volume":"3","author":"J Li","year":"2015","unstructured":"Li J, Jiang S, Zhang Y, Tang G, Wang Y, Mao G, et al. H-type hypertension and risk of stroke in Chinese adults: a prospective, nested case-control study. J Transl Intern Med. 2015;3(4):171\u20138.","journal-title":"J Transl Intern Med"},{"key":"3318_CR5","doi-asserted-by":"publisher","first-page":"1470788","DOI":"10.3389\/fnut.2024.1470788","volume":"11","author":"L Li","year":"2024","unstructured":"Li L, Wang J, Li J, Li M, Long T, Zhengliu Y, et al. The effect of cumulative exposure with unhealthy lifestyles on the H-type hypertension among Chinese adults: a community-based, propensity-score-matched, and case-control study. Front Nutr. 2024;11:1470788.","journal-title":"Front Nutr"},{"issue":"10","key":"3318_CR6","first-page":"796","volume":"18","author":"ZY Zhang","year":"2021","unstructured":"Zhang ZY, Gu X, Tang Z, Guan SC, Liu HJ, Wu XG, et al. Homocysteine, hypertension, and risks of cardiovascular events and all-cause death in the Chinese elderly population: a prospective study. J Geriatr Cardiol. 2021;18(10):796\u2013808.","journal-title":"J Geriatr Cardiol"},{"issue":"1","key":"3318_CR7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12872-021-01869-y","volume":"21","author":"J Sun","year":"2021","unstructured":"Sun J, Han W, Wu S, Jia S, Yan Z, Guo Y, et al. Associations between hyperhomocysteinemia and the presence and severity of acute coronary syndrome in young adults \u2264 35 years of age. BMC Cardiovasc Disord. 2021;21(1):47.","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"3318_CR8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12933-024-02555-x","volume":"24","author":"C Li","year":"2025","unstructured":"Li C, Zhao S, Li Y, He S, Jian W, Liu Y, et al. Triglyceride-glucose index predicts adverse cardiovascular events in patients with H-type hypertension combined with coronary heart disease: a retrospective cohort study. Cardiovasc Diabetol. 2025;24(1):45.","journal-title":"Cardiovasc Diabetol"},{"issue":"8","key":"3318_CR9","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1080\/14779072.2018.1497974","volume":"16","author":"SG Chrysant","year":"2018","unstructured":"Chrysant SG, Chrysant GS. The current status of homocysteine as a risk factor for cardiovascular disease: a mini review. Expert Rev Cardiovasc Ther. 2018;16(8):559\u201365.","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"21","key":"3318_CR10","first-page":"9582","volume":"23","author":"K Han","year":"2019","unstructured":"Han K, Lu Q, Zhu WJ, Wang TZ, Du Y, Bai L. Correlations of degree of coronary artery stenosis with blood lipid, CRP, Hcy, GGT, SCD36 and fibrinogen levels in elderly patients with coronary heart disease. Eur Rev Med Pharmacol Sci. 2019;23(21):9582\u20139.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"3318_CR11","doi-asserted-by":"publisher","first-page":"2457527","DOI":"10.1080\/07853890.2025.2457527","volume":"57","author":"W Tian","year":"2025","unstructured":"Tian W, Ju J, Guan B, Wang T, Zhang J, Song L, et al. Role of hyperhomocysteinemia in atherosclerosis: from bench to bedside. Ann Med. 2025;57(1):2457527.","journal-title":"Ann Med"},{"key":"3318_CR12","doi-asserted-by":"publisher","first-page":"124247","DOI":"10.1016\/j.lfs.2026.124247","volume":"389","author":"P Huang","year":"2026","unstructured":"Huang P, Zhang K, Chen Y, Cheng J, Yang S, Shi L, et al. HHcy promotes hypertension by activating ferroptosis via suppression of the renal H\u2082S-SLC7A11\/GPX4 axis. Life sci. 2026;389:124247.","journal-title":"Life sci"},{"issue":"1","key":"3318_CR13","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12933-020-0988-9","volume":"19","author":"T Lu","year":"2020","unstructured":"Lu T, Forgetta V, Yu OHY, Mokry L, Gregory M, Thanassoulis G, et al. Polygenic risk for coronary heart disease acts through atherosclerosis in type 2 diabetes. Cardiovasc Diabetol. 2020;19(1):12.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3318_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12933-023-01759-x","volume":"22","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Song H, Bai J, Xiu J, Wu G, Zhang L, et al. Association between the stress hyperglycemia ratio and severity of coronary artery disease under different glucose metabolic states. Cardiovasc Diabetol. 2023;22(1):29.","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"3318_CR15","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s12020-023-03389-5","volume":"81","author":"Y He","year":"2023","unstructured":"He Y, Li Z, Yu L, Liu Y, Li L, Yang R, et al. Association between the atherogenic index of plasma and carotid artery plaques in patients with coronary heart disease in different glucose metabolism states: an RCSCD-TCM study in Tianjin, China. Endocrine. 2023;81(2):252\u201361.","journal-title":"Endocrine"},{"issue":"1","key":"3318_CR16","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1186\/s12933-023-02015-y","volume":"22","author":"T Yang","year":"2023","unstructured":"Yang T, Zheng H, Pan G, Guo R, Liu F, Liu S, et al. Relationship between the circulating N-terminal pro B-type natriuretic peptide and the risk of carotid artery plaque in different glucose metabolic states in patients with coronary heart disease: a CSCD-TCM plus study in China. Cardiovasc Diabetol. 2023;22(1):299.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3318_CR17","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12933-023-01924-2","volume":"22","author":"XL Cai","year":"2023","unstructured":"Cai XL, Xiang YF, Chen XF, Lin XQ, Lin BT, Zhou GY, et al. Prognostic value of triglyceride glucose index in population at high cardiovascular disease risk. Cardiovasc Diabetol. 2023;22(1):198.","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"3318_CR18","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1210\/er.2018-00141","volume":"40","author":"A Di Pino","year":"2019","unstructured":"Di Pino A, DeFronzo RA. Insulin resistance and atherosclerosis: implications for insulin-sensitizing agents. Endocr Rev. 2019;40(6):1447\u201367.","journal-title":"Endocr Rev"},{"issue":"1","key":"3318_CR19","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s12933-024-02352-6","volume":"23","author":"W Li","year":"2024","unstructured":"Li W, Shen C, Kong W, Zhou X, Fan H, Zhang Y, et al. Association between the triglyceride glucose-body mass index and future cardiovascular disease risk in a population with Cardiovascular-Kidney-Metabolic syndrome stage 0-3: a nationwide prospective cohort study. Cardiovasc Diabetol. 2024;23(1):292.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3318_CR20","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12933-018-0762-4","volume":"17","author":"V Ormazabal","year":"2018","unstructured":"Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zu\u00f1iga FA. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018;17(1):122.","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"3318_CR21","doi-asserted-by":"publisher","first-page":"H1218","DOI":"10.1152\/ajpheart.00826.2024","volume":"328","author":"WB Horton","year":"2025","unstructured":"Horton WB, Love KM, Gregory JM, Liu Z, Barrett EJ. Metabolic and vascular insulin resistance: partners in the pathogenesis of cardiovascular disease in diabetes. Am J Physiol Heart Circ Physiol. 2025;328(6):H1218-h1236.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"3318_CR22","doi-asserted-by":"publisher","first-page":"154766","DOI":"10.1016\/j.metabol.2021.154766","volume":"119","author":"MA Hill","year":"2021","unstructured":"Hill MA, Yang Y, Zhang L, Sun Z, Jia G, Parrish AR, et al. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism. 2021;119:154766.","journal-title":"Metabolism"},{"issue":"5","key":"3318_CR23","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nrendo.2014.29","volume":"10","author":"M Laakso","year":"2014","unstructured":"Laakso M, Kuusisto J. Insulin resistance and hyperglycaemia in cardiovascular disease development. Nat Rev Endocrinol. 2014;10(5):293\u2013302.","journal-title":"Nat Rev Endocrinol"},{"issue":"-","key":"3318_CR24","doi-asserted-by":"publisher","first-page":"774781","DOI":"10.3389\/fcvm.2021.774781","volume":"8","author":"JW Luo","year":"2021","unstructured":"Luo JW, Duan WH, Yu YQ, Song L, Shi DZ. Prognostic significance of triglyceride-glucose index for adverse cardiovascular events in patients with coronary artery disease: a systematic review and meta-analysis. Front Cardiovasc Med. 2021;8:774781.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"3318_CR25","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12933-022-01546-0","volume":"21","author":"X Liu","year":"2022","unstructured":"Liu X, Tan Z, Huang Y, Zhao H, Liu M, Yu P, et al. Relationship between the triglyceride-glucose index and risk of cardiovascular diseases and mortality in the general population: a systematic review and meta-analysis. Cardiovasc Diabetol. 2022;21(1):124.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3318_CR26","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12933-023-01866-9","volume":"22","author":"Y Liu","year":"2023","unstructured":"Liu Y, Zhu B, Zhou W, Du Y, Qi D, Wang C, et al. Triglyceride-glucose index as a marker of adverse cardiovascular prognosis in patients with coronary heart disease and hypertension. Cardiovasc Diabetol. 2023;22(1):133.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3318_CR27","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13098-024-01568-6","volume":"17","author":"L Wang","year":"2025","unstructured":"Wang L, Li Z, Qiu R, Luo L, Yan X. Triglyceride glucose index-body mass index as a predictor of coronary artery disease severity in patients with H-type hypertension across different glucose metabolic states. Diabetol Metab Syndr. 2025;17(1):15.","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"3318_CR28","doi-asserted-by":"publisher","first-page":"4828","DOI":"10.1038\/s41598-025-89211-w","volume":"15","author":"Z Xu","year":"2025","unstructured":"Xu Z, Yan X, Li D, Huang X. Triglyceride glucose index as a biomarker for heart failure risk in H-type hypertension patients. Sci Rep. 2025;15(1):4828.","journal-title":"Sci Rep"},{"issue":"1","key":"3318_CR29","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12933-024-02244-9","volume":"23","author":"C Cui","year":"2024","unstructured":"Cui C, Liu L, Qi Y, Han N, Xu H, Wang Z, et al. Joint association of TyG index and high sensitivity C-reactive protein with cardiovascular disease: a national cohort study. Cardiovasc Diabetol. 2024;23(1):156.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3318_CR30","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12889-024-21131-2","volume":"25","author":"Y Cao","year":"2025","unstructured":"Cao Y, Wang W, Xie S, Xu Y, Lin Z. Joint association of the inflammatory marker and cardiovascular-kidney-metabolic syndrome stages with all-cause and cardiovascular disease mortality: a national prospective study. BMC Public Health. 2025;25(1):10.","journal-title":"BMC Public Health"},{"issue":"1","key":"3318_CR31","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12933-024-02207-0","volume":"23","author":"MG Rolver","year":"2024","unstructured":"Rolver MG, Emanuelsson F, Nordestgaard BG, Benn M. Contributions of elevated CRP, hyperglycaemia, and type 2 diabetes to cardiovascular risk in the general population: observational and Mendelian randomization studies. Cardiovasc Diabetol. 2024;23(1):165.","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"3318_CR32","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.ahj.2005.11.011","volume":"152","author":"D Aguilar","year":"2006","unstructured":"Aguilar D, Fisher MR, O\u2019Connor CM, Dunne MW, Muhlestein JB, Yao L, et al. Metabolic syndrome, C-reactive protein, and prognosis in patients with established coronary artery disease. Am Heart J. 2006;152(2):298\u2013304.","journal-title":"Am Heart J"},{"key":"3318_CR33","doi-asserted-by":"publisher","first-page":"905266","DOI":"10.3389\/fendo.2022.905266","volume":"13","author":"GT Ruan","year":"2022","unstructured":"Ruan GT, Xie HL, Zhang HY, Liu CA, Ge YZ, Zhang Q, et al. A novel inflammation and insulin resistance related indicator to predict the survival of patients with cancer. Front Endocrinol (Lausanne). 2022;13:905266.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"3318_CR34","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s12933-025-02848-9","volume":"24","author":"H Ou","year":"2025","unstructured":"Ou H, Wei M, Li X, Xia X. C-reactive protein-triglyceride glucose index in evaluating cardiovascular disease and all-cause mortality incidence among individuals across stages 0\u20133 of cardiovascular-kidney-metabolic syndrome: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24(1):296.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3318_CR35","doi-asserted-by":"publisher","first-page":"24687","DOI":"10.1038\/s41598-025-10184-x","volume":"15","author":"N Tang","year":"2025","unstructured":"Tang N, Chen X, Li H, Cheng S, Hu Y, Wang L, et al. Association of C reactive protein triglyceride glucose index with mortality in coronary heart disease and type 2 diabetes from NHANES data. Sci Rep. 2025;15(1):24687.","journal-title":"Sci Rep"},{"key":"3318_CR36","doi-asserted-by":"crossref","unstructured":"Shen K, Zhao J, Li K, Xu L, Wu H. Association between the C-reactive protein\u2013triglyceride\u2013glucose index and coronary heart disease in metabolic dysfunction-associated steatotic liver disease patients: a cross-sectional study. Front Endocrinol. 2026, 17(-):- .","DOI":"10.3389\/fendo.2026.1874886"},{"key":"3318_CR37","doi-asserted-by":"publisher","first-page":"1745588","DOI":"10.3389\/fendo.2025.1745588","volume":"16","author":"H Fan","year":"2025","unstructured":"Fan H, Xia D, Li J, Dong X. Association between elevated C-reactive protein-triglyceride-glucose index and in-hospital major adverse cardiovascular events in acute coronary syndrome patients after percutaneous coronary intervention: a single-center prospective observational study. Front Endocrinol. 2025;16:1745588.","journal-title":"Front Endocrinol"},{"issue":"9","key":"3318_CR38","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1161\/CIR.0000000000001168","volume":"148","author":"SS Virani","year":"2023","unstructured":"Virani SS, Newby LK, Arnold SV, Bittner V, Brewer LC, Demeter SH, et al. 2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American heart association\/American college of cardiology joint committee on clinical practice guidelines. Circulation. 2023;148(9):e9\u2013119.","journal-title":"Circulation"},{"issue":"2","key":"3318_CR39","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","volume":"41","author":"F Cosentino","year":"2020","unstructured":"Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, et al. 2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2020;41(2):255\u2013323.","journal-title":"Eur Heart J"},{"issue":"4","key":"3318_CR40","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/met.2008.0034","volume":"6","author":"LE Simental-Mend\u00eda","year":"2008","unstructured":"Simental-Mend\u00eda LE, Rodr\u00edguez-Mor\u00e1n M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299\u2013304.","journal-title":"Metab Syndr Relat Disord"},{"key":"3318_CR41","doi-asserted-by":"publisher","first-page":"e15463","DOI":"10.7717\/peerj.15463","volume":"11","author":"R Rattanatham","year":"2023","unstructured":"Rattanatham R, Tangpong J, Chatatikun M, Sun D, Kawakami F, Imai M, et al. Assessment of eight insulin resistance surrogate indexes for predicting metabolic syndrome and hypertension in Thai law enforcement officers. PeerJ. 2023;11:e15463.","journal-title":"PeerJ"},{"issue":"20","key":"3318_CR42","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1001\/jama.2023.7575","volume":"329","author":"SS Khan","year":"2023","unstructured":"Khan SS, Post WS, Guo X, Tan J, Zhu F, Bos D, et al. Coronary artery calcium score and polygenic risk score for the prediction of coronary heart disease events. Jama-j am med assoc. 2023;329(20):1768\u201377.","journal-title":"Jama-j am med assoc"},{"issue":"1","key":"3318_CR43","doi-asserted-by":"publisher","first-page":"e28162","DOI":"10.1002\/jmv.28162","volume":"95","author":"S Krishnamoorthy","year":"2023","unstructured":"Krishnamoorthy S, Li GH, Cheung CL. Transcriptome-wide summary data-based Mendelian randomization analysis reveals 38 novel genes associated with severe COVID-19. J Med Virol. 2023;95(1):e28162.","journal-title":"J Med Virol"},{"issue":"2","key":"3318_CR44","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/HJH.0000000000003002","volume":"40","author":"W Zhao","year":"2022","unstructured":"Zhao W, Gao F, Lv L, Chen X. The interaction of hypertension and homocysteine increases the risk of mortality among middle-aged and older population in the United States. J Hypertens. 2022;40(2):254\u201363.","journal-title":"J Hypertens"},{"issue":"23","key":"3318_CR45","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1016\/j.jacc.2009.09.009","volume":"54","author":"P Libby","year":"2009","unstructured":"Libby P, Ridker PM, Hansson GK. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol. 2009;54(23):2129\u201338.","journal-title":"J Am Coll Cardiol"},{"issue":"21 Suppl 1","key":"3318_CR46","first-page":"Ii2","volume":"109","author":"JT Willerson","year":"2004","unstructured":"Willerson JT, Ridker PM. Inflammation as a cardiovascular risk factor. Circulation. 2004;109(21 Suppl 1):Ii2-10.","journal-title":"Circulation"},{"issue":"20","key":"3318_CR47","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1161\/CIR.0b013e3182160726","volume":"123","author":"M Miller","year":"2011","unstructured":"Miller M, Stone NJ, Ballantyne C, Bittner V, Criqui MH, Ginsberg HN, et al. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2011;123(20):2292\u2013333.","journal-title":"Circulation"},{"issue":"4","key":"3318_CR48","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1093\/eurheartj\/ehi049","volume":"26","author":"A Ceriello","year":"2005","unstructured":"Ceriello A. Acute hyperglycaemia: a \u2018new\u2019 risk factor during myocardial infarction. Eur Heart J. 2005;26(4):328\u201331.","journal-title":"Eur Heart J"},{"issue":"1","key":"3318_CR49","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1186\/s12933-025-02960-w","volume":"24","author":"L Zhang","year":"2025","unstructured":"Zhang L, Li S, Liu D, Gui J, Hu J, Wang Q, et al. The relationship between C-reactive protein-triglyceride-glucose index and cardiovascular disease: insights from the China health and retirement longitudinal study (CHARLS). Cardiovasc Diabetol. 2025;24(1):410.","journal-title":"Cardiovasc Diabetol"},{"issue":"13","key":"3318_CR50","doi-asserted-by":"publisher","first-page":"e34194","DOI":"10.1016\/j.heliyon.2024.e34194","volume":"10","author":"X Yang","year":"2024","unstructured":"Yang X, Li L, Li R, Li P, Zhao H. Association between triglyceride-glucose index and sarcopenia in patients with chronic inflammatory airway disease. Heliyon. 2024;10(13):e34194.","journal-title":"Heliyon"},{"issue":"1","key":"3318_CR51","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12933-022-01523-7","volume":"21","author":"J Su","year":"2022","unstructured":"Su J, Li Z, Huang M, Wang Y, Yang T, Ma M, et al. Triglyceride glucose index for the detection of the severity of coronary artery disease in different glucose metabolic states in patients with coronary heart disease: a RCSCD-TCM study in China. Cardiovasc Diabetol. 2022;21(1):96.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3318_CR52","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12933-020-01108-2","volume":"19","author":"PV Thai","year":"2020","unstructured":"Thai PV, Tien HA, Van Minh H, Valensi P. Triglyceride glucose index for the detection of asymptomatic coronary artery stenosis in patients with type 2 diabetes. Cardiovasc Diabetol. 2020;19(1):137.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3318_CR53","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12933-023-02013-0","volume":"23","author":"Z Xu","year":"2024","unstructured":"Xu Z, Chen P, Wang L, Yan J, Yan X, Li D. Relationship between TyG index and the degree of coronary artery lesions in patients with H-type hypertension. Cardiovasc Diabetol. 2024;23(1):23.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3318_CR54","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12933-024-02159-5","volume":"23","author":"T Yang","year":"2024","unstructured":"Yang T, Li G, Wang C, Xu G, Li Q, Yang Y, et al. Insulin resistance and coronary inflammation in patients with coronary artery disease: a cross-sectional study. Cardiovasc Diabetol. 2024;23(1):79.","journal-title":"Cardiovasc Diabetol"},{"key":"3318_CR55","doi-asserted-by":"publisher","first-page":"1485538","DOI":"10.3389\/fcvm.2024.1485538","volume":"11","author":"M Xu","year":"1999","unstructured":"Xu M, Zhang L, Xu D, Shi W, Zhang W. Usefulness of C-reactive protein-triglyceride glucose index in detecting prevalent coronary heart disease: findings from the National Health and Nutrition Examination Survey 1999-2018. Front Cardiovasc Med. 1999;11:1485538.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"3318_CR56","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s13098-025-01687-8","volume":"17","author":"A Gao","year":"2025","unstructured":"Gao A, Peng B, Gao Y, Yang Z, Li Z, Guo T, et al. Evaluation and comparison of inflammatory and insulin resistance indicators on recurrent cardiovascular events in patients undergoing percutaneous coronary intervention: a single center retrospective observational study. Diabetol Metab Syndr. 2025;17(1):157.","journal-title":"Diabetol Metab Syndr"},{"key":"3318_CR57","doi-asserted-by":"crossref","unstructured":"Jin XF, Su ZJ, Zhong JF, Wang J, Shi BJ, Liu ZY, et al. Association of the C-reactive protein-triglyceride-glucose index with metabolic dysfunction-associated steatotic liver disease and long-term all-cause and cardiovascular mortality: evidence from two nationwide prospective cohort studies. Cardiovasc Diabetol. 2026, 25(1):- .","DOI":"10.1186\/s12933-026-03119-x"},{"key":"3318_CR58","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.biochi.2020.02.012","volume":"173","author":"B Balint","year":"2020","unstructured":"Balint B, Jepchumba VK, Gu\u00e9ant JL, Gu\u00e9ant-Rodriguez RM. Mechanisms of homocysteine-induced damage to the endothelial, medial and adventitial layers of the arterial wall. Biochimie. 2020;173:100\u20136.","journal-title":"Biochimie"},{"issue":"Suppl 1","key":"3318_CR59","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/sj.cdd.4401451","volume":"11","author":"RC Austin","year":"2004","unstructured":"Austin RC, Lentz SR, Werstuck GH. Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease. Cell death differ. 2004;11(Suppl 1):56\u201364.","journal-title":"Cell death differ"},{"key":"3318_CR60","doi-asserted-by":"crossref","unstructured":"Jakubowski H, Witucki \u0141. Homocysteine metabolites, endothelial dysfunction, and cardiovascular disease. Int J Mol Sci. 2025, 26(2):- .","DOI":"10.3390\/ijms26020746"},{"issue":"10","key":"3318_CR61","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1161\/CIRCRESAHA.116.308501","volume":"118","author":"H Xi","year":"2016","unstructured":"Xi H, Zhang Y, Xu Y, Yang WY, Jiang X, Sha X, et al. Caspase-1 inflammasome activation mediates homocysteine-induced pyrop-apoptosis in endothelial cells. Circ Res. 2016;118(10):1525\u201339.","journal-title":"Circ Res"},{"issue":"1","key":"3318_CR62","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12933-024-02122-4","volume":"23","author":"RR Huo","year":"2024","unstructured":"Huo RR, Liao Q, Zhai L, You XM, Zuo YL. Interacting and joint effects of triglyceride-glucose index (TyG) and body mass index on stroke risk and the mediating role of TyG in middle-aged and older Chinese adults: a nationwide prospective cohort study. Cardiovasc Diabetol. 2024;23(1):30.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3318_CR63","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s12933-025-02835-0","volume":"24","author":"Y Sun","year":"2025","unstructured":"Sun Y, Guo Y, Ma S, Mao Z, Meng D, Xuan K, et al. Association of C-reactive protein-triglyceride glucose index with the incidence and mortality of cardiovascular disease: a retrospective cohort study. Cardiovasc Diabetol. 2025;24(1):313.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3318_CR64","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s12933-025-02876-5","volume":"24","author":"Y Chen","year":"2025","unstructured":"Chen Y, Jia W, Guo J, Yang H, Sheng X, Wei L, et al. Association between the C-reactive protein-triglyceride glucose index and new-onset coronary heart disease among metabolically heterogeneous individuals. Cardiovasc Diabetol. 2025;24(1):316.","journal-title":"Cardiovasc Diabetol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-026-03318-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03318-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03318-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:47:18Z","timestamp":1790686038000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12933-026-03318-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,9]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3318"],"URL":"https:\/\/doi.org\/10.1186\/s12933-026-03318-6","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,9]]},"assertion":[{"value":"2 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study protocol was approved by the Ethics Committee of the Wuhan Third Hospital (KY2026-025), the study complied with the Declaration of Helsinki, and written informed consent was obtained from all participants.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"295"}}